The next board meeting for BridgeBio Pharma Inc is on 23 Sep 2026 for the purpose of Bernstein Insights Healthcare Leaders and Disruptors 2026See details
BridgeBio Pharma Inc has a share price target of US$ 109, revenue growth forecast of 104.5%, and profit growth estimate of 25.6% for FY26, based on top 22 analyst calls.